NCT05737511View on ClinicalTrials.gov

Efficacy of Hydroxyzine for Patients With Panic Disorder

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 30, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Panic Disorder
Interventions
DRUG

Hydroxyzine

Oral tablet of hydroxyzine 25mg at night which could be increased to TID or QID

DRUG

Escitalopram Oxalate

The treatment as usual can include first-line, second-line and third-line recommendations

All Listed Sponsors
lead

Sultan Qaboos University

OTHER